モダリスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/04 | 1,301 | 1,335 | 1,290 | 1,302 | -24 | -1.8% | 158,500 |
2021/06/03 | 1,369 | 1,369 | 1,318 | 1,326 | -44 | -3.2% | 191,000 |
2021/06/02 | 1,395 | 1,405 | 1,358 | 1,370 | -1 | -0.1% | 125,700 |
2021/06/01 | 1,362 | 1,379 | 1,340 | 1,371 | +9 | +0.7% | 155,100 |
2021/05/31 | 1,412 | 1,412 | 1,359 | 1,362 | -51 | -3.6% | 174,900 |
2021/05/28 | 1,433 | 1,439 | 1,400 | 1,413 | -42 | -2.9% | 182,400 |
2021/05/27 | 1,421 | 1,455 | 1,389 | 1,455 | +34 | +2.4% | 216,100 |
2021/05/26 | 1,435 | 1,452 | 1,405 | 1,421 | -15 | -1% | 130,300 |
2021/05/25 | 1,402 | 1,436 | 1,396 | 1,436 | +27 | +1.9% | 140,500 |
2021/05/24 | 1,400 | 1,425 | 1,371 | 1,409 | -18 | -1.3% | 243,800 |
2021/05/21 | 1,383 | 1,456 | 1,360 | 1,427 | +59 | +4.3% | 316,600 |
2021/05/20 | 1,317 | 1,383 | 1,314 | 1,368 | +24 | +1.8% | 282,200 |
2021/05/19 | 1,296 | 1,407 | 1,295 | 1,344 | +20 | +1.5% | 498,900 |
2021/05/18 | 1,170 | 1,326 | 1,118 | 1,324 | -73 | -5.2% | 1,626,500 |
2021/05/17 | 1,468 | 1,468 | 1,392 | 1,397 | -71 | -4.8% | 316,700 |
2021/05/14 | 1,426 | 1,468 | 1,396 | 1,468 | +42 | +2.9% | 254,500 |
2021/05/13 | 1,473 | 1,475 | 1,420 | 1,426 | -48 | -3.3% | 306,500 |
2021/05/12 | 1,500 | 1,561 | 1,465 | 1,474 | -43 | -2.8% | 385,000 |
2021/05/11 | 1,549 | 1,553 | 1,495 | 1,517 | -55 | -3.5% | 534,700 |
2021/05/10 | 1,690 | 1,690 | 1,572 | 1,572 | -134 | -7.9% | 728,000 |
2021/05/07 | 1,653 | 1,736 | 1,632 | 1,706 | -2 | -0.1% | 510,300 |
2021/05/06 | 1,785 | 1,787 | 1,694 | 1,708 | -76 | -4.3% | 449,200 |
2021/04/30 | 1,804 | 1,806 | 1,763 | 1,784 | -36 | -2% | 235,000 |
2021/04/28 | 1,884 | 1,884 | 1,813 | 1,820 | -70 | -3.7% | 167,200 |
2021/04/27 | 1,927 | 1,929 | 1,883 | 1,890 | -30 | -1.6% | 126,700 |
2021/04/26 | 1,873 | 1,924 | 1,843 | 1,920 | +42 | +2.2% | 185,100 |
2021/04/23 | 1,891 | 1,926 | 1,864 | 1,878 | -49 | -2.5% | 113,800 |
2021/04/22 | 1,895 | 1,927 | 1,895 | 1,927 | +63 | +3.4% | 97,500 |
2021/04/21 | 1,912 | 1,937 | 1,856 | 1,864 | -84 | -4.3% | 217,500 |
2021/04/20 | 1,940 | 1,976 | 1,922 | 1,948 | -5 | -0.3% | 163,400 |
2021/04/19 | 1,996 | 2,005 | 1,951 | 1,953 | -59 | -2.9% | 231,800 |
2021/04/16 | 2,015 | 2,030 | 1,994 | 2,012 | +19 | +1% | 101,600 |
2021/04/15 | 1,996 | 2,017 | 1,984 | 1,993 | +6 | +0.3% | 122,100 |
2021/04/14 | 2,003 | 2,019 | 1,985 | 1,987 | -18 | -0.9% | 206,100 |
2021/04/13 | 2,012 | 2,033 | 1,999 | 2,005 | -23 | -1.1% | 145,400 |
2021/04/12 | 2,061 | 2,079 | 2,020 | 2,028 | -62 | -3% | 149,100 |
2021/04/09 | 2,008 | 2,102 | 1,986 | 2,090 | +85 | +4.2% | 290,000 |
2021/04/08 | 2,005 | 2,023 | 1,990 | 2,005 | ±0 | ±0% | 216,100 |
2021/04/07 | 2,050 | 2,050 | 2,004 | 2,005 | -49 | -2.4% | 210,500 |
2021/04/06 | 2,090 | 2,094 | 2,043 | 2,054 | -48 | -2.3% | 157,000 |
2021/04/05 | 2,159 | 2,159 | 2,092 | 2,102 | -58 | -2.7% | 124,500 |
2021/04/02 | 2,150 | 2,173 | 2,140 | 2,160 | -8 | -0.4% | 66,200 |
2021/04/01 | 2,119 | 2,175 | 2,087 | 2,168 | +80 | +3.8% | 189,600 |
2021/03/31 | 2,095 | 2,132 | 2,067 | 2,088 | -57 | -2.7% | 252,500 |
2021/03/30 | 2,080 | 2,150 | 2,064 | 2,145 | +115 | +5.7% | 326,900 |
2021/03/29 | 2,112 | 2,144 | 1,997 | 2,030 | -116 | -5.4% | 429,600 |
2021/03/26 | 2,194 | 2,209 | 2,106 | 2,146 | -13 | -0.6% | 317,400 |
2021/03/25 | 2,211 | 2,230 | 2,026 | 2,159 | -2 | -0.1% | 606,700 |
2021/03/24 | 2,338 | 2,370 | 2,116 | 2,161 | -27 | -1.2% | 678,700 |
2021/03/23 | 2,238 | 2,238 | 2,174 | 2,188 | -35 | -1.6% | 75,900 |
851~
900
件表示中 / 1056件
類似銘柄と比較する
現在ご覧いただいている「モダリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.55倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
カイオム | 18,000円 | +2.6% | - | 0.00% | - | 10.61倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.35倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
ケイファーマ | 73,000円 | -100.0% | - | 0.00% | - | 3.16倍 |
|
慶応大学発医療ベンチャー。iPS細胞による再生医療と創薬の2本柱。中枢神経系が得意領域 |
市場注目の銘柄
チャート関連のコラム